282 related articles for article (PubMed ID: 22363864)
1. Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.
Piérard GE
ISRN Dermatol; 2012; 2012():828146. PubMed ID: 22363864
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways supporting the proliferation staging of malignant melanoma (review).
Quatresooz P; Pierard GE; Pierard-Franchimont C;
Int J Mol Med; 2009 Sep; 24(3):295-301. PubMed ID: 19639220
[TBL] [Abstract][Full Text] [Related]
3. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis.
Han X; Jia Y; Chen X; Sun C; Sun J
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165
[TBL] [Abstract][Full Text] [Related]
4. LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis.
Wang K; Luo Q; Zhang Y; Xie X; Cheng W; Yao Q; Chen Y; Ren H; Li J; Pan Z
Aging (Albany NY); 2022 Dec; 15(8):2877-2890. PubMed ID: 36462499
[TBL] [Abstract][Full Text] [Related]
5. Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns.
Piérard-Franchimont C; Hermanns-Lê T; Delvenne P; Piérard GE
Oncol Rev; 2014 Sep; 8(2):252. PubMed ID: 25992239
[TBL] [Abstract][Full Text] [Related]
6. The role of melanocortin 1 receptor in cutaneous malignant melanoma: along the mitogen-activated protein kinase pathway.
Steck MB
Biol Res Nurs; 2014 Oct; 16(4):421-8. PubMed ID: 24443365
[TBL] [Abstract][Full Text] [Related]
7. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
8. GSTO1 regards as a meritorious regulator in cutaneous malignant melanoma cells.
Wang LK; Yue HL; Peng XJ; Zhang SJ
Mol Cell Probes; 2019 Dec; 48():101449. PubMed ID: 31525447
[TBL] [Abstract][Full Text] [Related]
9. AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma.
Das I; Gad H; Bräutigam L; Pudelko L; Tuominen R; Höiom V; Almlöf I; Rajagopal V; Hansson J; Helleday T; Egyházi Brage S; Warpman Berglund U
Cell Death Differ; 2020 Jul; 27(7):2081-2098. PubMed ID: 31919461
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
11. RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
Heerfordt IM; Philipsen PA; Andersen JD; Langhans L; Schmidt G; Morling N; Wulf HC
J Am Acad Dermatol; 2023 Sep; 89(3):537-543. PubMed ID: 37224970
[TBL] [Abstract][Full Text] [Related]
12. Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patients.
Privitera E; Ghidoni A; Raimondi E; Rovini D; Illeni MT; Cascinelli N
Cancer Genet Cytogenet; 1985 Feb; 15(1-2):37-45. PubMed ID: 3967218
[TBL] [Abstract][Full Text] [Related]
13. [Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma].
Wu Y; Zhang XB; Liu HJ; Zheng LD; Li JW; Lin Y
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):466-9. PubMed ID: 17845760
[TBL] [Abstract][Full Text] [Related]
14. MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Cancer Res Ther; 2018; 14(Supplement):S60-S64. PubMed ID: 29578151
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
Taran JM; Heenan PJ
Cancer; 2001 May; 91(9):1822-5. PubMed ID: 11335909
[TBL] [Abstract][Full Text] [Related]
16. Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.
Benfodda M; Gazal S; Descamps V; Basset-Seguin N; Deschamps L; Thomas L; Lebbe C; Saiag P; Zanetti R; Sacchetto L; Chiorino G; Scatolini M; Grandchamp B; Bensussan A; Soufir N
Genes Chromosomes Cancer; 2018 Jun; 57(6):294-303. PubMed ID: 29359367
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of ovostatin 2 reveals its involvement in proliferation, invasion and angiogenesis of cutaneous malignant melanoma.
Huang YX; Qi J; Wang HS; Shao XB; Zeng XS; Li AM; Xu XL; Sun JF
J Dermatol; 2013 Nov; 40(11):901-10. PubMed ID: 24112097
[TBL] [Abstract][Full Text] [Related]
18. The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma.
Cappabianca L; Zelli V; Pellegrini C; Sebastiano M; Maccarone R; Clementi M; Chiominto A; Ruggeri P; Cardelli L; Ruggieri M; Sbaffone M; Fargnoli MC; Guadagni S; Farina AR; Mackay AR
Cells; 2023 Jan; 12(2):. PubMed ID: 36672171
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a regulates the development of cutaneous malignant melanoma by mediating FOXP1.
Sun HW; Yang GL; Wang SN; Zhang YJ; Ding JX; Zhang XN
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8991-8999. PubMed ID: 31696487
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma and its stromal nonimmune microecosystem.
Piérard GE; Piérard-Franchimont C; Delvenne P
J Oncol; 2012; 2012():584219. PubMed ID: 22811710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
